ANDA 201354, held by Chartwell Rx. Colesevelam Hydrochloride.
As of Nov 15, 2026, ANDA 201354 (Colesevelam Hydrochloride), held by Chartwell Rx, was first approved by FDA on Dec 17, 2020, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 17, 2020 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Colesevelam Hydrochloride625MG · tablet;oral | Colesevelam Hydrochloride | Discontinued |
| Aug 22, 2022 | Supplement 1Labeling · Standard review | Approved | None posted |
| Dec 17, 2020 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters